Spectral AI (NASDAQ: MDAI) is scheduled to announce its third-quarter earnings for fiscal year 2025 after the market closes on November 11, 2025. Analysts anticipate the company will report a loss of $0.08 per share, alongside revenue projections of approximately $5.0620 million for the quarter. The earnings call will take place at 5:00 PM ET, and investors are encouraged to check the company’s overview page for the latest updates leading up to the announcement.
In its previous earnings report on August 12, 2025, Spectral AI reported a loss of $0.10 per share, falling short of the consensus estimate of a loss of $0.07 by $0.03. The company generated revenue of $5.07 million, which was below the expected $5.44 million. As a result, analysts have adjusted their forecasts for the current fiscal year, predicting an average earnings per share (EPS) of $0 and a loss of $1 EPS for the next fiscal year.
Market Performance and Institutional Interest
As of Friday, MDAI shares opened at $1.94. The stock has experienced fluctuations, evidenced by a 50-day simple moving average of $2.17 and a 200-day simple moving average of $2.08. Spectral AI currently holds a market capitalization of $53.58 million, with a price-to-earnings ratio of -2.81 and a beta of 0.91. The stock’s performance has varied, with a 12-month low of $1.01 and a high of $3.25.
Several institutional investors have recently adjusted their stakes in Spectral AI. Jane Street Group LLC acquired a new position valued at approximately $74,000 during the second quarter. Similarly, Marshall Wace LLP invested $104,000 in the company, while XTX Topco Ltd purchased shares worth $123,000. Notably, Geode Capital Management LLC increased its holdings by 21.8%, now owning 152,958 shares valued at $379,000. Currently, institutional investors and hedge funds own 67.08% of Spectral AI’s stock.
Analysts’ Ratings and Future Outlook
Recent reports from analysts indicate a cautious outlook for Spectral AI. Weiss Ratings reiterated a “sell (e+)” rating on the shares in a report published on October 31, 2025. Meanwhile, Wall Street Zen downgraded the stock from a “hold” to a “strong sell” rating earlier in August. Currently, one investment analyst has assigned a Buy rating, while another has rated it as a Sell. Overall, data from MarketBeat shows a consensus rating of “Hold” for MDAI, with an average price target of $3.50.
Spectral AI is an artificial intelligence company focused on developing predictive medical diagnostics in the United States. The company aims to enhance treatment decisions for wound care, particularly for patients suffering from burns and diabetic foot ulcers. As the earnings announcement approaches, stakeholders are closely monitoring the company’s performance and market positioning.
